Metal-based glycoconjugates for the targeted anticancer chemotherapy
Titilas, Ioannis
Titilas, Ioannis
Loading...
Publication Date
2023-08-30
Type
Thesis
Downloads
Citation
Abstract
Rapidly dividing tumor cells require higher amounts of nutrients and energy to sustain their abnormal proliferation rates, and glucose is no exception. Glucose enters the cell by facilitated diffusion through the glucose transporters (GLUTs) and, subsequently, undergoes a series of biochemical steps to produce energy mostly through the highly efficient oxidative phosphorylation process in mitochondria (36 ATPs produced per molecule of glucose) in normal cells. On the contrary, aerobic glycolysis was proved to be the major glucose metabolic pathway in tumor sites (the so-called “Warburg effect”) which is less efficient (4 ATPs/glucose) but occurring at a faster rate. Consequently, cancer cells over-express GLUTs to facilitate glucose internalization in order to satisfy their greater demand for energy. Such increased need for glucose by cancer cells makes it very attractive to selectively target tumor sites. In particular, tailored glucose-like substrates can be conjugated to chemotherapeutics (including metallodrugs) to attain the site-specific intracellular drug transfer and delivery by taking advantage of the over-expression of GLUTs in cancer cells. Within the field of metal-based anticancer agents, some metal-dithiocarbamato complexes have previously shown outstanding in vitro and in vivo antitumor activity together with negligible systemic and organ toxicity (owing to the intrinsic chemoprotective function of the coordinated dithiocarbamato moiety), although selective tumor targeting is still a major issue. On the basis of the aforementioned considerations, the present PhD research work has been focusing on the design of metal-dithiocarbamato glycoconjugates which can combine the antitumor properties and the favorable toxicological profile of the metal-dithiocarbamato scaffold, along with an improved selectivity and cellular uptake provided by the glucose-containing ligands coordinated to the metal center, through the exploitation of the glucose-mediated cellular internalization provided by GLUTs. Specifically, a complete set of Au(I)-, Au(III)- and Pt(II)- dithiocarbamato derivatives of D- and L-glucose has been generated, as well as their nonglycosylated analogues. All complexes have been fully characterized by IR, NMR and UV-Vis spectroscopy, and their stability in solution (DMSO and PBS) and lipophilicity have been evaluated. Preliminary in vitro cytotoxicity studies have been carried out towards a panel of human tumor cell lines, showing that the inclusion of a glucose-like scaffold decreases the antiproliferative activity of the metal-dithiocarbamato core. Interestingly, the D-glucose derivatives generally exhibit greater cytotoxicity than their L-glucose counterparts, which seems to support the hypothesis of the involvement (at least to some extent) of GLUTs in their cell internalization mechanism. However, further in vitro tests carried out in presence of specific GLUTs inhibitors proved somewhat inconclusive.
Funder
Publisher
NUI Galway